European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the leading franchisor and operator of out-of-home waxing services in the United States, announced that on March 21, ...

Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product candidate, IMM-1-104 ...

The approved inducement grant comes as Etsy targets a stickier app experience as part of a strategy to reverse an ongoing ...

These inducement stock options and inducement RSUs are subject ... the closing price of Travere’s common stock on the date of grant, are non-qualified stock options, have a 10-year term and vest over ...

The inducement equity awards were granted effective as of March ... price of Ocular’s common stock on The Nasdaq Global Market on the effective date of grant, and (ii) a restricted stock unit award ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib fo ...

The stock option granted on November 5, 2024 has a ten-year term and an exercise price of $3.59 per share, which is equal to the closing sales price per share of the Company’s common shares on the ...

The awards were granted as an inducement material to the employees entering into employment with Gossamer in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $ ...

Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 13,351 shares of the Company’s common stock to 16 new employees. The awards were ...